Patents by Inventor Yunfeng Zhao

Yunfeng Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120327989
    Abstract: An embodiment of the present invention provides a smart feed line automation system based on 10 kV carrier communication. The system monitors smart switches of the line via 10 kV carrier communication, detects smart transformers, and calls up and returns centralized meter-reading information of smart transformer region. Furthermore, the detection of the state of a 10 kV power line may realize real-time monitoring of the temperature, insulating level and change of voltage and current of a 10 kV aerial line and cable line, and realize alarm for an abnormal state and fault information report, so as to rapidly identify, position, isolate and recover the fault.
    Type: Application
    Filed: December 28, 2011
    Publication date: December 27, 2012
    Applicant: Shanxilinfen Power Supply Company
    Inventors: Jianzhong Zhang, Limin Zhai, Qi Wei, Yunfeng Zhao, Zhiyuan Xie, Yihe Guo, Wanjun Wu, Weimin Zheng, Zhonghua Xi, Xintian Guan, Yong Zhang, Jianyun Jin, Jinping Sun
  • Publication number: 20120135012
    Abstract: Cell suicide (apoptosis) is associated with pathogenesis, for example, it is the major cause for the loss of neurons in Alzheimer's disease. Caspase-3 is critically involved in the pathway of apoptosis. Superantibody (SAT)-trans-membrane technology has been used to produce antibodies against the caspase enzyme in an effort to inhibit apoptosis in living cells. The advantage of using trans-membrane antibodies as apoptosis inhibitors is their specific target recognition in the cell and their lower toxicity compared to conventional apoptosis inhibitors. It is shown that a MTS-transport-peptide modified monoclonal anti-caspase-3 antibody reduces actinomycin D-induced apoptosis and cleavage of spectrin in living cells. These results indicate that antibodies conjugated to a membrane transporter peptide have a therapeutic potential to inhibit apoptosis in a variety of diseases.
    Type: Application
    Filed: November 22, 2011
    Publication date: May 31, 2012
    Applicant: InNexus Biotechnology Inc.
    Inventors: Heinz Kohler, Sybille Müller, Thomas L. Brown, Yunfeng Zhao, A. Charles Morgan
  • Publication number: 20120120180
    Abstract: The utility model relates to a 3G multimedia dispatching command system, which belongs to the field of dispatching command system, comprising: a 3G public network, a dispatching platform, an access exchanger, a core exchanger, a core access gateway, a management terminal, a multimedia terminal device, an IP telephone server, and a duplex intercom server, through which a stable structure is constructed to implement a thousand-user simultaneous duplex cluster intercom without space or distance limitation, the conversation is clear without any noise, like the quality of a telephone call. The utility model also has functions of video transmission, personnel location, dispatching sound recording and mobile meeting. The communication is free of charge, the work and communication may be performed simultaneously to ensure the security, and the system can be applied in a wide range.
    Type: Application
    Filed: November 17, 2011
    Publication date: May 17, 2012
    Applicant: Shanxilinfen Power Supply Company
    Inventors: Jianyun Jin, Yong Li, Yunfeng Zhao, Weimin Zheng, Zhonghua Xi, Gang Lu, Lihu Guo, Jinping Sun
  • Publication number: 20090274710
    Abstract: Cell suicide (apoptosis) is associated with pathogenesis, for example, it is the major cause for the loss of neurons in Alzheimer's disease. Caspase-3 is critically involved in the pathway of apoptosis. Superantibody (SAT)-trans-membrane technology has been used to produce antibodies against the caspase enzyme in an effort to inhibit apoptosis in living cells. The advantage of using trans-membrane antibodies as apoptosis inhibitors is their specific target recognition in the cell and their lower toxicity compared to conventional apoptosis inhibitors. It is shown that a MTS-transport-peptide modified monoclonal anti-caspase-3 antibody reduces actinomycin D-induced apoptosis and cleavage of spectrin in living cells. These results indicate that antibodies conjugated to a membrane transporter peptide have a therapeutic potential to inhibit apoptosis in a variety of diseases.
    Type: Application
    Filed: April 9, 2009
    Publication date: November 5, 2009
    Applicant: InNexus Biotechnology International Limited
    Inventors: Heinz Kohler, Sybille Muller, Thomas L. Brown, Yunfeng Zhao, A. Charles Morgan, JR.
  • Publication number: 20050033033
    Abstract: Cell suicide (apoptosis) is associated with pathogenesis, for example, it is the major cause for the loss of neurons in Alzheimer's disease. Caspase-3 is critically involved in the pathway of apoptosis. Superantibody (SAT)-trans-membrane technology has been used to produce antibodies against the caspase enzyme in an effort to inhibit apoptosis in living cells. The advantage of using trans-membrane antibodies as apoptosis inhibitors is their specific target recognition in the cell and their lower toxicity compared to conventional apoptosis inhibitors. It is shown that a MTS-transport-peptide modified monoclonal anti-caspase-3 antibody reduces actinomycin D-induced apoptosis and cleavage of spectrin in living cells. These results indicate that antibodies conjugated to a membrane transporter peptide have a therapeutic potential to inhibit apoptosis in a variety of diseases.
    Type: Application
    Filed: March 5, 2004
    Publication date: February 10, 2005
    Inventors: Heinz Kohler, Sybille Muller, Thomas Brown, Yunfeng Zhao, A. Morgan